Boule Diagnostics AB Share Price
Stocks
BOUL
SE0011231158
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Nasdaq Stockholm
09:30:00 08/10/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 2.350 SEK | -4.08% |
|
+4.44% | -52.14% |
| 06/10 | Boule Diagnostics, Q-Line Biotech Update Long-term India License Deal | MT |
| 06/10 | Boule Diagnostics updates licensing agreement in India | FW |
| Market Cap | 9.51Cr 95.12L 84.95L 79.24L 71.98L 1.35Cr 92Cr 1.37Cr 3.72Cr 47Cr 3.57Cr 3.49Cr 150.56Cr | P/E 2026 * |
-9.73x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 29Cr 2.92Cr 2.6Cr 2.43Cr 2.21Cr 4.15Cr 282.45Cr 4.19Cr 11Cr 143.53Cr 11Cr 11Cr 461.58Cr | EV / Sales 2026 * |
0.64x | EV / Sales 2027 * | 0.58x |
| Free-Float |
53.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Stockholm
| BOUL | Delayed | |
CBOE
| 0P4Z | Real-time | |
|
CBOE
| BOULs | Real-time |
Last Transcript: Boule Diagnostics AB
| 1 day | -4.08% | ||
| 1 week | +4.44% | ||
| Current month | +1.29% | ||
| 1 month | -23.20% | ||
| 3 months | -38.32% | ||
| 6 months | -40.05% | ||
| Current year | -52.14% |
| 1 week | 2.22 |  | 2.83 |
| 1 month | 2.21 | | 3.01 |
| Current year | 2.21 | | 5.68 |
| 1 year | 2.21 | | 6.64 |
| 3 years | 2.21 | | 12.62 |
| 5 years | 2.21 | | 59.5 |
| 10 years | 2.21 | | 108.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Johan Folkunger
CEO | Chief Executive Officer | - | 22/06/2026 |
| Director of Finance/CFO | 54 | 11/02/2026 | |
Lucy Yehiayan
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 01/01/2014 | |
| Chairman | 73 | 01/01/2021 | |
| Chairman | 74 | 01/01/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 27/02/23 | Buy | Chief Financial Officer | 8,000 | 0.0206% | ||
| 06/02/23 | Buy | Director | 7,083 | 0.0182% | ||
| 17/02/22 | Buy | Director | 2,000 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.08% | +4.44% | -53.74% | -75.90% | 94.98L | |
| -1.52% | -0.06% | +21.62% | +31.44% | 24TCr | |
| -0.48% | +2.65% | +6.05% | -0.46% | 15TCr | |
| +0.21% | +3.59% | -7.24% | +41.14% | 15TCr | |
| +1.11% | -2.89% | -56.63% | -19.89% | 6.03TCr | |
| -1.80% | -1.11% | +11.23% | +15.56% | 4.94TCr | |
| -0.57% | +0.85% | +19.38% | +51.06% | 4.77TCr | |
| -0.78% | +1.73% | -21.18% | -18.56% | 4.8TCr | |
| +0.83% | +1.01% | -5.64% | +33.60% | 4.57TCr | |
| -1.53% | +1.08% | +31.27% | +61.10% | 4.28TCr | |
| Average | -0.84% | -0.99% | -5.49% | +11.91% | 8.39TCr | |
| Weighted average by Cap. | -0.73% | -2.10% | +3.93% | +22.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 4.53Cr 4.05Cr 3.77Cr 3.43Cr 6.45Cr 438.77Cr 6.51Cr 18Cr 222.96Cr 17Cr 17Cr 717.05Cr | 48Cr 4.83Cr 4.32Cr 4.03Cr 3.66Cr 6.88Cr 468.02Cr 6.95Cr 19Cr 237.82Cr 18Cr 18Cr 764.85Cr |
| Net income | -97.73L -10L -9L -8L -7L -13.91L -9.46Cr -14.05L -38.23L -4.81Cr -36.69L -35.89L -15Cr | 85.96L 9L 8L 7L 7L 12.24L 8.32Cr 12.36L 33.62L 4.23Cr 32.27L 31.57L 14Cr |
| Net Debt | 20Cr 1.97Cr 1.75Cr 1.64Cr 1.49Cr 2.8Cr 190.32Cr 2.83Cr 7.69Cr 97Cr 7.38Cr 7.22Cr 311.03Cr | 18Cr 1.84Cr 1.65Cr 1.54Cr 1.4Cr 2.63Cr 178.67Cr 2.65Cr 7.22Cr 91Cr 6.93Cr 6.78Cr 291.99Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | SEK 2.350 | -4.08% | 1,30,954 |
| 07/26/07 | SEK 2.450 | +7.93% | 38,310 |
| 06/26/06 | SEK 2.270 | -2.99% | 40,647 |
| 05/26/05 | SEK 2.340 | -2.90% | 11,826 |
| 02/26/02 | SEK 2.410 | +7.11% | 15,213 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BOUL Stock
Select your edition
All financial news and data tailored to specific country editions
